New Apr 3, 2025Immunogenicity and safety of monovalent and bivalent SARS-CoV-2 variant adapted RBD-based protein booster vaccines in adults previously immunized with different vaccine platforms: A phase II/III, randomized clinical trial
Perez Marc G, Coria LM, Ceballos A, et al. — Laboratorio Pablo Cassará group for ARVAC.
View full publication
New Apr 2024Immunogenicity and safety of a recombinant protein SARS-CoV-2 booster vaccine (Gamma, Omicron BA.4/5 and bivalent)
Randomized Phase II/III clinical trial in adults previously vaccinated with different platforms.
View full publication
Jul 28, 2023
Safety and immunogenicity of a SARS-CoV-2 Gamma variant RBD-based protein adjuvanted vaccine used as booster in healthy adults
ARVAC CG vaccine, first-in-human clinical trial.
View full publication
May 18, 2021
Pharmacokinetics of a new fixed-dose combination of candesartan cilexetil, hydrochlorothiazide, and rosuvastatin in healthy adult subjects
Pharmacokinetic study of a fixed-dose combination for cardiovascular disease.
View full publication
Jul 12, 2021
Clinical investigation of the biopharmaceutical characteristics of nifurtimox tablets – Implications for quality control and application
Nifurtimox 120mg, Chagas disease.
View full publication
Apr 27, 2021
FV-RE-10 VD01 Audit Record – FP Clinical Pharma (Argentina)
Audit of the process for collecting, evaluating, interpreting, coding and reporting adverse reactions (Spedrog Caillón).
View full publication
Sep 2, 2020
Biopharmaceutical Characteristics of Nifurtimox Tablets for Age and Body Weight-Adjusted Dosing in Patients With Chagas Disease
120mg and 30mg formulations for pediatric dosing.
View full publication
Sep 13, 2019
Comparative Bioavailability of a New Fixed Dose Combination Tablet Containing Lumacaftor/Ivacaftor in Healthy Subjects
Crossover study, single dose, 2 pathways. Cystic fibrosis.
View full publication
Sep 5, 2017
Comparative Bioavailability of Two Oral Perampanel Formulations in Healthy Subjects
Open-label, crossover, single-dose study, 2 pathways. Antiepileptic.
View full publication
2016
Effect of a high-calorie, high-fat meal on the pharmacokinetics of oral nifurtimox in adults with chronic Chagas' disease
Phase I food-effect study.
View full publication
Jul 2016
Plasma Enalapril Kinetics of Two Modified Formulations Tested in Healthy Volunteers
Search for optimal blood pressure control.
View full publication
Sep 2015
Pharmacokinetic Drug-drug Interaction Study of Benznidazole and E1224 in Healthy Male Volunteers
Chagas disease: Benznidazole and Ravuconazole interaction.
View full publication
2011
Single-Dose Bioequivalence of a New Fixed-Dose Combination Tablet Containing Tenofovir Disoproxil Fumarate and Lamivudine
Fixed-dose combination, antiretroviral therapy (HIV).
View full publication
2011
Bioequivalence study of two oral tablet formulations containing saquinavir mesylate boosted with ritonavir
Highly active antiretroviral therapy (HAART).
View full publication
2011
Bioequivalence study of two oral tablet formulations containing tenofovir disoproxil fumarate in healthy volunteers
Management of HIV-1 infection.
View full publication
Mar 2011
Healthy volunteers for bioequivalence trials: predictive factors for enrollment failures - a case-control study
Predictive factors for healthy volunteer enrollment failures.
View full publication
2003
Basic Principles in Pharmaceutical Product Research
From the synthesis of a new drug in the laboratory to Phase I trials.
View full publication
Oct 29, 2009
Single-Dose Bioequivalence Study of Mycophenolate Mofetil 500 in Healthy Volunteer Subjects
Immunosuppressive therapy for solid organ transplants (Laboratorios Sandoz).
View full publication
Mar 9, 2010
Relative Bioavailability of Two Drug Products of Somatropin Obtained from Either the Milk of Transgenic Cows or Bacterial Culture
Recombinant human growth hormone (hGH).
View full publication
Jun 26, 2021
Journal Pre-proof: Clinical investigation of the biopharmaceutical characteristics of nifurtimox tablets
Stass H, Just S, Weimann B, Ince I, Willmann S, Feleder E, Freitas C, Yerino G, Münster U.
View full publication
Oct 29, 2009
Single-Dose Bioequivalence Study of Zidovudine, Abacavir and Lamivudine in Healthy Volunteers (Trivudin® and Tricivir®)
Combined antiretroviral therapy for HIV (Laboratorios Richmond).
View full publication
